Infective endocarditis and spondylodiscitis—impact of sequence of surgical therapy on survival and recurrence rate
European Journal of Cardio-Thoracic Surgery · 2024
DOI: 10.1093/ejcts/ezae246 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Carolyn Weber und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Discitis, Recurrence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES To date, there are no standardized treatment algorithms or recommendations for patients with infective endocarditis (IE) and concomitant spondylodiscitis (SD). Therefore, our aim was to analyse whether the sequence of surgical treatment of IE and SD has an impact on postoperative outcome and to identify risk factors for survival and postoperative recurrence. METHODS Patients with IE underwent surgery in 4 German university hospitals between 1994 and 2022. Univariable and multivariable analyses were performed to identify possible predictors of 30-day/1-year mortality and recurrence of IE and/or SD. RESULTS From the total IE cohort (n = 3991), 150 patients (4.4%) had concomitant SD. Primary surgery for IE was performed in 76.6%, and primary surgery for SD in 23.3%. The median age was 70.0 (64.0–75.6) years and patients were mostly male (79.5%). The most common pathogens detected were enterococci and Staphylococcus aureus followed by streptococci, and coagulase-negative Staphylococci. If SD was operated on first, 30-day mortality was significantly higher than if IE was operated on 1st (25.7% vs 11.4%; P = 0.037) and we observed a tendency for a higher 1-year mortality. If IE was treated 1st, we observed a higher recurrence rate within 1 year (12.2% vs 0%; P = 0.023). Multivariable analysis showed that primary surgery for SD was an independent predictor of 30-day mortality. CONCLUSIONS Primary surgical treatment for SD was an independent risk factor for 30-day mortality. When IE was treated surgically 1st, the recurrence rate of IE and/or SD was higher.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, University of Cologne, Cologne, Germany.
- University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.
- Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia.
- Department of Cardiothoracic Surgery, Friedrich Schiller University Jena, Jena, Germany.
- Department of Cardiac Surgery, HKZ Klinikum Herfeld-Rotenburg Rotenburg a.d. Fulda, Germany.
- Department of Cardiac Surgery, Ludwig Maximilian University of Munich, Munich, Germany.
ORCID-Profile: Carolyn Weber, Shekhar Saha, Torsten Doenst, Michael A Borger, Thorsten Wahlers
Zitieren
APA
Weber, C., Misfeld, M., Diab, M., Saha, S., Elderia, A., Marin-Cuartas, M., Luehr, M., Yagdiran, A., Eysel, P., Jung, N., Hagl, C., Doenst, T., Borger, M. A., Kernich, N., & Wahlers, T. (2024). Infective endocarditis and spondylodiscitis—impact of sequence of surgical therapy on survival and recurrence rate. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae246
Vancouver
Weber C, Misfeld M, Diab M, Saha S, Elderia A, Marin-Cuartas M, et al. Infective endocarditis and spondylodiscitis—impact of sequence of surgical therapy on survival and recurrence rate. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae246
BibTeX
@article{Weber2024,
author = {Weber, Carolyn and Misfeld, Martin and Diab, Mahmoud and Saha, Shekhar and Elderia, Ahmed and Marin-Cuartas, Mateo and Luehr, Maximilian and Yagdiran, Ayla and Eysel, Peer and Jung, Norma and Hagl, Christian and Doenst, Torsten and Borger, Michael A and Kernich, Nikolaus and Wahlers, Thorsten},
title = {Infective endocarditis and spondylodiscitis—impact of sequence of surgical therapy on survival and recurrence rate},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
doi = {10.1093/ejcts/ezae246}
}
EUVIMED